Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 59(1): 157-70, 2016 Jan 14.
Article in English | MEDLINE | ID: mdl-26704594

ABSTRACT

A series of triphenylethylene bisphenol analogues of the selective estrogen receptor modulator (SERM) tamoxifen were synthesized and evaluated for their abilities to inhibit aromatase, bind to estrogen receptor α (ER-α) and estrogen receptor ß (ER-ß), and antagonize the activity of ß-estradiol in MCF-7 human breast cancer cells. The long-range goal has been to create dual aromatase inhibitor (AI)/selective estrogen receptor modulators (SERMs). The hypothesis is that in normal tissue the estrogenic SERM activity of a dual AI/SERM could attenuate the undesired effects stemming from global estrogen depletion caused by the AI activity of a dual AI/SERM, while in breast cancer tissue the antiestrogenic SERM activity of a dual AI/SERM could act synergistically with AI activity to enhance the antiproliferative effect. The potent aromatase inhibitory activities and high ER-α and ER-ß binding affinities of several of the resulting analogues, together with the facts that they antagonize ß-estradiol in a functional assay in MCF-7 human breast cancer cells and they have no E/Z isomers, support their further development in order to obtain dual AI/SERM agents for breast cancer treatment.


Subject(s)
Aromatase Inhibitors/chemical synthesis , Aromatase Inhibitors/pharmacology , Phenols/chemical synthesis , Phenols/pharmacology , Selective Estrogen Receptor Modulators/chemical synthesis , Selective Estrogen Receptor Modulators/pharmacology , Stilbenes/chemical synthesis , Stilbenes/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Catalytic Domain/drug effects , Cell Line, Tumor , DNA, Complementary/biosynthesis , DNA, Complementary/drug effects , Estrogen Receptor alpha/drug effects , Estrogen Receptor beta/drug effects , Female , Humans , Microsomes/drug effects , Microsomes/enzymology , Models, Molecular , Molecular Docking Simulation , RNA, Neoplasm/biosynthesis , RNA, Neoplasm/drug effects , Recombinant Proteins/chemical synthesis , Recombinant Proteins/pharmacology , Stereoisomerism
2.
J Med Chem ; 58(9): 3997-4015, 2015 May 14.
Article in English | MEDLINE | ID: mdl-25909279

ABSTRACT

3-Nitroindenoisoquinoline human topoisomerase IB (Top1) poisons have potent antiproliferative effects on cancer cells. The undesirable nitro toxicophore could hypothetically be replaced by other functional groups that would retain the desired biological activities and minimize potential safety risks. Eleven series of indenoisoquinolines bearing 3-nitro bioisosteres were synthesized. The molecules were evaluated in the Top1-mediated DNA cleavage assay and in the National Cancer Institute's 60 cell line cytotoxicity assay. The data reveal that fluorine and chlorine may substitute for the 3-nitro group with minimal loss of Top1 poisoning activity. The new information gained from these efforts can be used to design novel indenoisoquinolines with improved safety.


Subject(s)
Antineoplastic Agents/chemistry , Indenes/chemistry , Isoquinolines/chemistry , Topoisomerase I Inhibitors/chemistry , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Crystallography, X-Ray , DNA/metabolism , Drug Screening Assays, Antitumor , Humans , Hydrogen Bonding , Indenes/chemical synthesis , Indenes/pharmacology , Isoquinolines/chemical synthesis , Isoquinolines/pharmacology , Molecular Conformation , Protein Binding , Quantum Theory , Stereoisomerism , Structure-Activity Relationship , Thermodynamics , Topoisomerase I Inhibitors/chemical synthesis , Topoisomerase I Inhibitors/pharmacology
3.
Molecules ; 19(12): 21200-14, 2014 Dec 16.
Article in English | MEDLINE | ID: mdl-25521119

ABSTRACT

In an effort to study the effects of flexibility on enzyme recognition and activity, we have developed several different series of flexible nucleoside analogues in which the purine base is split into its respective imidazole and pyrimidine components. The focus of this particular study was to synthesize the truncated neplanocin A fleximers to investigate their potential anti-protozoan activities by inhibition of S-adenosylhomocysteine hydrolase (SAHase). The three fleximers tested displayed poor anti-trypanocidal activities, with EC50 values around 200 µM. Further studies of the corresponding ribose fleximers, most closely related to the natural nucleoside substrates, revealed low affinity for the known T. brucei nucleoside transporters P1 and P2, which may be the reason for the lack of trypanocidal activity observed.


Subject(s)
Adenosine/analogs & derivatives , Trypanocidal Agents/chemical synthesis , Adenosine/chemical synthesis , Adenosine/metabolism , Adenosine/pharmacology , Adenosylhomocysteinase/antagonists & inhibitors , Adenosylhomocysteinase/metabolism , Biological Transport , Drug Design , Drug Evaluation, Preclinical , Inhibitory Concentration 50 , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/metabolism , Trypanocidal Agents/metabolism , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/drug effects , Trypanosoma brucei brucei/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...